Seroprevalence of anti-SARS-CoV-2 antibodies after the second pandemic peak

Lancet Infect Dis. 2021 Feb 1;S1473-3099(21)00054-2. doi: 10.1016/S1473-3099(21)00054-2. Online ahead of print.
No abstract available

Publication types

  • Letter